New drug combo aims to control rare blood cancers
NCT ID NCT06034002
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 23 times
Summary
This early-stage study tests a new drug, INCA033989, given alone or with another drug (ruxolitinib) in people with certain blood cancers (myeloproliferative neoplasms). The main goals are to check safety and find the best dose. About 290 adults with these cancers will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOPROLIFERATIVE NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
-
Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
-
Icahn School of Medicine At Mount Sinai
RECRUITINGNew York, New York, 10029, United States
-
Johns Hopkins Hospital
RECRUITINGBaltimore, Maryland, 21287, United States
-
Md Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
-
Stanford Cancer Institute
RECRUITINGPalo Alto, California, 94304, United States
-
The University of Kansas Cancer Center
RECRUITINGWestwood, Kansas, 66205, United States
-
University of Miami Health System
RECRUITINGMiami, Florida, 33136, United States
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
-
Wake Forest Baptist Medical Center
RECRUITINGWinston-Salem, North Carolina, 27157, United States
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63108, United States
Conditions
Explore the condition pages connected to this study.